- Country: Guatemala
- Summary: Event No. 2050-2024 Order 6327 Ref. 48580 Igss Code 872 Lidocaine Hydrochloride Without Epinephrine, Without Preservative Injectable Solution 2%, Vial or Ampoule 10 Ml- 20 Ml Quantity 690
- GTT Ref No: 106804781
- Deadline: 06 Sep 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 24011770
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Event No. 2050-2024 Order 6327 Ref. 48580 Igss Code 872 Lidocaine Hydrochloride Without Epinephrine, Without Preservative Injectable Solution 2%, Vial Or Ampoule 10 Ml- 20 Ml Quantity 690
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINEvent No. 2050-2024 Order 6327 Ref. 48580 Igss Code 872 Lidocaine Hydrochloride Without Epinephrine, Without Preservative Injectable Solution 2%, Vial or Ampoule 10 Ml- 20 Ml Quantity 690 - Guatemala Tender
The GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS-, a Government sector organization in Guatemala, has announced a new tender for Event No. 2050-2024 Order 6327 Ref. 48580 Igss Code 872 Lidocaine Hydrochloride Without Epinephrine, Without Preservative Injectable Solution 2%, Vial or Ampoule 10 Ml- 20 Ml Quantity 690. This tender is published on GuatemalaTenders under GTT Ref No: 106804781 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-09-06.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
